Oxytocin Identity Guide: Nonapeptide, Disulfide and Stability
Oxytocin is a cyclic nonapeptide with a Cys1–Cys6 disulfide bridge and a C-terminal amide. Sequence, disulfide state, counterion, aggregation and potency are…
Read source review →
Research Topic
Reproductive & Hormone
Topic knowledge
Source-reviewed reading for reproductive & hormone
Continue from catalog navigation into editorial analysis, evidence records and quality-documentation guidance.
Showing 7–12 of 12 reviewed articles · Page 2 of 2
Oxytocin Evidence Guide: Physiology, Label and Claim Boundaries
Oxytocin is both an endogenous hormone and a regulated prescription drug. Established obstetric uses do not validate every social, mood, bonding or…
Read source review →Kisspeptin-10 vs Kisspeptin-54: Sequence and Amidation Guide
Kisspeptin-10 is the C-terminal decapeptide YNWNSFGLRF-amide. It shares an active C-terminal region with longer kisspeptins but is not the same material as…
Read source review →Kisspeptin-10 and LH Pulses: The Small Human Physiology Study
A 2011 study established that kisspeptin-10 can acutely stimulate luteinizing-hormone secretion in healthy men. Its detailed pulse data are valuable physiology, but…
Read source review →PT-141/Bremelanotide: Free Base, Acetate and Finished-Drug Boundary
PT-141 is the development code associated with bremelanotide. A free-base peptide, its acetate form and the approved finished injection are related records,…
Read source review →Bremelanotide RECONNECT Trials: Endpoints, Safety and FDA Scope
Bremelanotide has a real FDA-approved finished-drug record, but its scope is narrow. The RECONNECT trials studied premenopausal women with acquired, generalized HSDD—not…
Read source review →Need a peptide for reproductive & hormone research?
If a target is not listed, submit the sequence, scale and specification for a custom-project feasibility review.